All Stories

  1. Effectiveness and gastrointestinal tolerability during conversion and titration with once-daily OROS® hydromorphone extended release in opioid-tolerant patients with chronic low back pain

    Article • Journal of Pain Research, May 2013, Taylor & Francis

    Mr Michael Kutch

  2. Safety and Tolerability of Once-Daily OROS® Hydromorphone Extended-Release in Opioid-Tolerant Adults With Moderate-to-Severe Chronic Cancer and Noncancer Pain: Pooled Analysis of 11 Clinical Studies

    Article • Journal of Pain and Symptom Management, December 2012, Elsevier

    Mr Michael Kutch

  3. Safety and tolerability of OROS® hydromorphone ER in adults with chronic noncancer and cancer pain: Pooled analysis of 13 studies

    Article • Journal of Opioid Management, September 2012, Weston Medical Publishing

    Mr Michael Kutch

  4. Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain

    Article • Current Medical Research and Opinion, April 2010, Informa Healthcare

    Mr Michael Kutch